<DrugInformationSummary id="CDR0000791122"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Abemaciclib works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow. Blocking these proteins may slow or stop the growth of cancer cells. Abemaciclib is a type of targeted therapy drug called a kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/abemaciclib">Abemaciclib</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000706364">abemaciclib</TerminologyLink><GlossaryLink ref="CDR0000791149">abemaciclib</GlossaryLink><USBrandNames><USBrandName>Verzenio</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>uh-BEH-muh-SY-klib</TermPronunciation><MediaLink ref="CDR0000792245" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000792244" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be4bc0de-0fdc-4d46-8d25-be43c79e6a06&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Abemaciclib</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be4bc0de-0fdc-4d46-8d25-be43c79e6a06&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Abemaciclib
         is approved to be used alone or with other drugs to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000788029" dictionary="Cancer.gov" audience="Patient">hormone receptor positive</GlossaryTermRef> (HR+) and <GlossaryTermRef href="CDR0000774531" dictionary="Cancer.gov" audience="Patient">HER2 negative</GlossaryTermRef> (HER2-).  <ItemizedList Style="bullet" id="_6"><ListItem>In adults with <GlossaryTermRef href="CDR0000446564" dictionary="Cancer.gov" audience="Patient">early-stage breast cancer</GlossaryTermRef> that has spread to the <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> and has a high risk of coming back, it is used with <GlossaryTermRef href="CDR0000509341" dictionary="Cancer.gov" audience="Patient">tamoxifen citrate</GlossaryTermRef> or an <GlossaryTermRef href="CDR0000044232" dictionary="Cancer.gov" audience="Patient">aromatase inhibitor</GlossaryTermRef> as <GlossaryTermRef href="CDR0000045587" dictionary="Cancer.gov" audience="Patient">adjuvant therapy</GlossaryTermRef>.</ListItem><ListItem>In adults whose cancer has spread (<GlossaryTermRef href="CDR0000478743" dictionary="Cancer.gov" audience="Patient">advanced</GlossaryTermRef> or <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef>).  It is used:<ItemizedList Style="bullet" id="_7"><ListItem>with <GlossaryTermRef href="CDR0000306498" dictionary="Cancer.gov" audience="Patient">fulvestrant</GlossaryTermRef> for cancer that got worse after treatment with <GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">hormone therapy</GlossaryTermRef></ListItem><ListItem>alone for cancer that got worse after treatment with hormone therapy and chemotherapy given for <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef> cancer</ListItem><ListItem>with an aromatase inhibitor given as <GlossaryTermRef href="CDR0000346494" dictionary="Cancer.gov" audience="Patient">first-line</GlossaryTermRef> hormone therapy in men and <GlossaryTermRef href="CDR0000045269" dictionary="Cancer.gov" audience="Patient">postmenopausal</GlossaryTermRef> women</ListItem></ItemizedList></ListItem></ItemizedList></ListItem>
   
   </ItemizedList>
  <Para id="_5">Abemaciclib
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Abemaciclib</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/706364">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.28">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a617049.html">Abemaciclib</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.29"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.30">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/meningioma-brain-tumor-new-classifications">New Way to Classify Meningioma Brain Tumors Suggests Potential Treatments</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C97660">Find Clinical Trials for Abemaciclib</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2017-10-03</DateFirstPublished><DateLastModified>2024-12-23</DateLastModified></DrugInformationSummary>
